Adapting and testing of DeprEnd EMDR therapy for major depressive disorder: a study protocol of mixed method randomized controlled trial
Description
Discussion
This research conducts the first known scientific adaptation and clinical testing of the DeprEnd EMDR therapy protocol in Pakistan. Through systematic adaptation and assessment of its feasibility and clinical effectiveness, this protocol is positioned to be scalable, showing potentials for broader dissemination across South Asia. It contributes a vital framework for culturally sensitive mental health interventions that bridge global evidence-based practices and local sociocultural needs. This study paves way for collaborative efforts to optimize traumafocused psychotherapies in low-resource contexts, thus promoting health equity in the region.
This research conducts the first known scientific adaptation and clinical testing of the DeprEnd EMDR therapy protocol in Pakistan. Through systematic adaptation and assessment of its feasibility and clinical effectiveness, this protocol is positioned to be scalable, showing potentials for broader dissemination across South Asia. It contributes a vital framework for culturally sensitive mental health interventions that bridge global evidence-based practices and local sociocultural needs. This study paves way for collaborative efforts to optimize traumafocused psychotherapies in low-resource contexts, thus promoting health equity in the region.
Format
Journal
Language
English
Original Work Citation
Khan, A., Madihie, A., Haider, M., Haider, S., Khan, R., & Bahadar, S. (2026). Adapting and testing of DeprEnd EMDR therapy for major depressive disorder: a study protocol of mixed method randomized controlled trial. Trials. https://doi.org/10.1186/s1306 3-026-09543-4
Collection
Citation
“Adapting and testing of DeprEnd EMDR therapy for major depressive disorder: a study protocol of mixed method randomized controlled trial,” Francine Shapiro Legacy Library, accessed May 16, 2026, https://francineshapirolibrary.omeka.net/items/show/30431.